— Know what they know.
Not Investment Advice
Also trades as: NAN.AX (ASX) · $vol 2M

NNCSF OTC

Nanosonics Limited
1W: +1.0% 1M: +5.7% 3M: -20.0% YTD: -29.7% 1Y: -28.4% 3Y: -39.5% 5Y: -64.4%
$2.04
+0.02 (+0.79%)
 
Weekly Expected Move ±2.4%
$2 $2 $2 $2 $2
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 55 · $608.6M mcap · 255M float · 0.0002% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$608.6M
52W Range1.93-3.06
Volume450
Avg Volume632
Beta1.20
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael C. Kavanagh
Employees508
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2012-08-13
Building A
Macquarie Park, NSW 2113
AU
61 2 8063 1600
About Nanosonics Limited

Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories. Furthermore, Nanosonics is committed to the research, development, and market introduction of innovative infection control and decontamination products and related technologies. Its product portfolio features the trophon2, a sophisticated device for high-level disinfection of ultrasound probes; trophon EPR, a specialized low-temperature, high-level disinfection solution specifically for intra-cavity ultrasound transducers; and Nanosonics AuditPro, a comprehensive system for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited maintains its corporate headquarters in Macquarie Park, Australia.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms